Good MorningThe equities market went on a wild ride on Thursday following a series of blow-out reports from top names on Wall Street. Among them are Apple, Microsoft, eBay, and Ford but the mood was dampened by growing indications of doom for the market. As robust as the growth outlook is, the estimates may be too high because of the global chip shortage. More than a few S&P 500 companies have noted the shortage and its impact on future revenue. In addition, talk of higher taxes continues in Washington and added its cloud to the outlook.
Friday is going to be a make-or-break moment for the major indices. If the indices can hold their ground at these new highs going into the close of the week further upside is more likely than not. If, however, the mood on Wall Street sours and the market moves lower on Friday it could mark the beginning of a correction that has been brewing for months.
Featured: Breaking Now: Biden's Disturbing Plan to "Reset" America (Legacy Research) 
|
Stocks | | | We’ve put together a list of 3 high-yield dividend stocks to buy for income below to help you sort through the “dividend traps” and only select the best quality names for your portfolio. Keep reading below to learn more. Read the Full Story |
|
From Our PartnersOne of the biggest gold discoveries may be under the drills of this small-cap explorer! | | | | Continue Reading |
|
Tech | | | After reporting blowout first-quarter earnings after the market closed on April 28, Align Technology (NASDAQ:ALGN) stock took a sharp break to the upside on higher-than-average volume in early trading Read the Full Story |
|
Politics | | | Asian shares were mostly lower Friday amid uncertainty about the prospects for a global economic recovery from the coronavirus pandemic.
Japan's benchmark Nikkei 225 dipped 0.7% in afternoon trading to 28,844.39. South Korea's Kospi slipped 0.9% to 3,146.04. Australia's S&P/ASX 2... Read the Full Story |
|
From Our PartnersWith experts projecting gains as high as 1,530% by the end of this year…
If you don't buy this ticker, you'll regret it later. | | | | Learn more here! |
|
Stocks | | |
With U.S. stocks trading near record highs, low-priced stocks have been hard to come by. Only 15 of the S&P 500 constituents have a share price below $20. The story is similar in the mid-cap space where only 25 S&P 400 stocks can be had for less than an Andrew Jackson bill.
This means tha... Read the Full Story |
|
Stocks | | | Advertising and marketing have gone through a massive transformation over the last few decades thanks to the rise of the internet and cutting-edge technological advances. The days when businesses could solely rely on traditional advertising methods like direct mail, billboards, flyers, and radio &am... Read the Full Story |
|
From Our PartnersThis little-known stock market signal could help you retire RICH… | | | | Continue Reading |
|
Markets | | | Europe's economy shrank 0.6% in the first three months of the year as slow vaccine rollouts and extended lockdowns delayed a hoped-for recovery and underlined how the region is lagging other major economies in rebounding from the coronavirus pandemic.
The fall in output was smaller t... Read the Full Story |
|
Markets | | | Shares rose in early European trading on Friday after retreating in Asia as the latest batch of economic data provided mixed signals about prospects for the recovery from the pandemic.
Two surveys released Friday showed Chinese manufacturing expanded in April but growth appeared to b... Read the Full Story |
|
Politics | | | PARIS — France has announced its first confirmed cases of the virus variant that is sweeping over India, just as the French president outlined a national reopening plan after six months of virus restrictions.
The Health Ministry announced late Thursday night that three people tested p... Read the Full Story |
|
Tech | | | Chinese financial regulators have summoned 13 companies engaged in online finance services, including Tencent and Bytedance, and told them to strengthen anti-monopoly measures.
The regulators, which include the People’s Bank of China (PBOC) and China’s securities and banking regulato... Read the Full Story |
|
Markets | | | The Hershey Company (NYSE: HSY) Q1 results are a great example of what we like so much about the consumer staples sector. Like so many in the sector, The Hershey Company has itself positioned for growth while giving value Read the Full Story |
|
The Early Bird Stock Of The Day CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an an oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTI BioPharma Corp. has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. and S*BIO Pte Ltd. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington. | | View Today's Stock Pick |
|
